Professional Documents
Culture Documents
DNA uranon o on )
platu
. genowi e libur (oh squ enws)
3. CDNA ibrutxns Annealing (s0-9c)
4uwbon- are
N No. Df clors prim
probability e certhin C.I 4that a
In (1-4) (equent i« rtaMstn kd at lat a partHud a
2 DNA
a. 4/. C
gbein
g
Constructing CDNA
isolal kNA COMA
#{nylon pap attndh
cON liprafy cangtuho Tran ded needs
Singte DNA gat
hahure nRNA txtacHoh uheoti de stauentt
-
wid fype
one as
H agaw al)
19D b (put
I00V
op (2D mins
bom giros qe
Mas
The Fight Againgt r p i aak odn
covip-19 PCRDNNA
2014 n vinus (pande mic) -PtRMautaa
New Ag+
CARc Thetádemi
Six ytats beht 4hewine fflu Pandit -ARS
nnt Pndjc- polymernte
ab
CoViD4
o respivnh ny ideess Cud by cnbavira(SARS-CV-2) 4W CoTDnAviph
nevl (new) vins = COV
Cortaviu ewtptiza
1 fHunan
Alpha .
Brn Upak
HCoy-NL3 ucahiag - DNA
tov22E - A a n in thhc code
Ptlta Jbrirn HCov-Oc43 -
in seik p
pho i Lon
CovD-14 inkt
18P of Vauisg n)
Cormavins k prtri
cell wil e
Siwna
inkuri yps in
rpirabny tnet
DNA RN vis
SARS-CoV-2
Spike
TMPRS$2 SARS-CoV-2
s
Spike
Furin protein
Healthy
ACE2 air sac (alveoli)
TMPRSS2 Furin
ACE2
Host cell
TCL
19 infect?
Healthy airspace
with airflow
Alrways swelling
and decreaslng
airflow
Healthy
air sac (alveoli) Inflammation
in alveolar walls
C
Group A, B, C, D
Belacoronavirus Gammacoronavirus Deltacoronavia
Jenus Alphacoronavirus
HCoV-NL63, HCoV-OC43,
HCoV-229E HCoV-HKU1,
SARS,
MERS,
Wu et al., 2012. 0O: 10.1128/M.0CSS
CoV-2
Primary
host
Coronavirus
Cross-species Bat
ransmssion/
2002 230 years ag0 2019
Secondary/
host
Human
Tertiary Coronavinus
host
Human
SARS-CoV-1, MERS, and SARS-
CoV-2 likely all emerged from
bats and were transferred to
humans via intermediate hosts
A civit cat
Why has COV-2 been
control than SARS? so much harder to
Cov-1/SARS
Spillover reservoir known: civit cats cov-2/covID-19
Most transmission
occurred in Spillover reservoir unknown
hospital setting Widespread community transmission
(hubs)
No transmission until 24-36 h after
Lack of asymptomatic symptoms Abundant asymptomatic/mild cases
symptoms
Pandemic Endemic
Epidemic Consistently present in
Spreads rapidly across
Spreads rapidly within a the population, with
finite geographical area several countries,
relatively low spread
continents, or the world
ooo0000o
o00000
000OO00
OOOO0
0000 00
56M
Small Pox
1520 40-50M
Spanish Flu 30-50M
1918-1919 Plague of Justinlan
541-542
200 M
Bubonic Plague
1347-1361
25-35M 12M M
HIV/AIDS The Third Plague 3M 1.1M IM
1981- PRESENT 5
Antonine 17th Centuy Aslan Flu
1M M
Plague Russlan Flu Hong Kong Flu
Great Plagues 57-1958 1889-1890
Cholera 6
165.1 1665 1968-197 outbreak
1817-1923
1M 600K 200K 4.7K
100-15 11.3K Novel Coronavirus 850
Japanese 18th Century Swine Flu Yellow Fever Ebola
(CoviD-19) MERS
770
SARS
mallpox Epldemic Great Plagues 2009-2010 LATE 1800s 2014-2016 2019 PRESENT 2015.PRESENT 2002.200
735-737
1817-1923
FOURWAYS TO DESTROY CORONAVIRUS
1 SOAPAND WATER BLEACH SOLUTION
sOONM MYPOCHLOBTE
Dot ma ble xh mithotter cleaners
Dissotres ta fato
Dasetres i wta This tan generate taae chlorine gas
Coronaviruses are a group of viruses The specific coronavirus HANDS ARD suRFACES MANDS MARD SUus ACES
that causes CcoVID-19 is calted SARS-CoV-2
H,0
OH OH
oEOCKPRaroE
-Ewelepe
Nacteocapsld (fatty Layer )
Oon1 mis peraide thyinegar
(made of prota in) ETHANOL 150PROPANO This mahrs corrovve per xetk Kd
Evnlope protain
Viral ga nom
MINIMUM CONCENTRATION OF O.S% PEROXIDE
(genatk materta)
-spia protei MIN.60%ALCOHOL (HANDS) OR70% (SURFACES)
NOW DOES T CESTROY TE vIRUST
HOW DOES T DESTROYTHE VIRUS?
ucleocapsld
nade of proteln)
Envelope
(fatty layer)
al genome
netic materlal) -Emvelope protein
Spleproteln MIN. 60%
ARS-CoV-2 is a new
virus, so there's
tBy cleaning hands currently no
and surfaces we can stop it treatment Alcohol mole=
spreading and d
Andy Brunning/Compound
Interest
This graphic is shared
under a 2020-www.Attribution-NonCom
Creative Commons compoundchem.com
History of
Vaccination
Pioneered in 1796 by Edward Jenner in
England
TYPES OF VACCINES
Whole inactivated
(nectlvated vins)
UU
M
Synthetic peptide
(Laboratory-made
plece of prolein)
Omcron
Epsllon Lambda CineageMu
B.1.621) (lneage B.1.1.529)
(lineages Kappa
(6ublineage
lota
B.1.617.1)(ineageB.1.526) (ineegeC.37
B.1.427/B.1.429)
Was the development of COVID vaccine
rushed?
bSeunoaRy A helix plead uheet tran fer RNA s aminoam KNA ynthetece
CLhapeB)
ca vrV o or intyact t the mRNA
9RTaRy polerephke ( %0)nalT 0dapfrtins Hrn -odoni loo p
bind
S
NDA OVr KoPR CP6
RI Bo So E
taor mo0ni ne a t wilengble thansah/on bpokik ynTe Jiu
a TKIPLeT JubVnitf 6p a
aCH CODOn Protcin Rna Molewlty m po he w
it ill reuy "y 1
Ir on anto bnly oho lettr
a) PotarapN bUkavyoi
in t e
- e t ik) hA beer dea yla ttd heh ces into fiogmens
rJHinE DeL GARJ RapF eodey the inha thon Con, tCO R (eco R fve Vsed CU open
he ingkeri q pu the art cdon vectbr *d 0 a gene ot in eres
o ploumid
S' AA GCTT . 8
0Tihahtot ompA
3 11 CG A S
STFV n TKans LdTndn orlofmion
amineacytRNa Y ephdc
Enyme 1arget Seqvence Clecav 04e
ondetmN
Trans louhon E-6 5'GAATTCS AATTC
aina.acu tKlnd
rAnleganbi ta RV
3CrTARG G'_
'6ATHC 3'
3 CT THGS
'1TTC
s'GATA
nianon of anLanon
no tRna that peunes the op Codon
Lpnkalyolcg)
RF 1 Seupi FOr UAf and
DATE